Skip to content

Parkinson’s disease and Small Fiber Neuropathy (SFN)

Introduction to Parkinson’s disease

Description:

Parkinson’s disease is a progressive nervous system disorder that affects movement. Symptoms start gradually, sometimes starting with a barely noticeable tremor in just one hand. Tremors are common, but the disorder also commonly causes stiffness or slowing of movement. In the early stages of Parkinson’s disease, your face may show little or no expression. Your arms may not swing when you walk. Your speech may become soft or slurred. Parkinson’s disease symptoms worsen as your condition progresses over time.

The exact cause of Parkinson’s is unknown, but several factors appear to play a role, including:

  • Genes: Researchers have identified specific genetic mutations that can cause Parkinson’s. However, these are uncommon except in rare cases with many family members affected by Parkinson’s.
  • Environmental triggers: Exposure to certain toxins or environmental factors may increase the risk of later Parkinson’s disease, but the risk is relatively small.

Prevalence:

Parkinson’s disease affects more than 10 million people worldwide, according to the Parkinson’s Foundation. In the United States, approximately 60,000 new cases are diagnosed each year, adding to the one million people who currently have Parkinson’s disease.

Risk Factors:

Several factors can increase the risk of developing Parkinson’s disease:

  • Age: Parkinson’s disease typically begins in middle or late life, and the risk increases with age. People usually develop the disease around age 60 or older.
  • Heredity: Having a close relative with Parkinson’s disease increases the chances that you’ll develop the disease. However, your risks are still small unless you have many relatives in your family with Parkinson’s disease.
  • Sex: Men are more likely to develop Parkinson’s disease than women.
  • Exposure to toxins: Ongoing exposure to herbicides and pesticides may slightly increase your risk of Parkinson’s disease.

Prognosis:

Parkinson’s disease is a chronic and progressive disease, meaning it continues and worsens over time. But although Parkinson’s may eventually be disabling, the disease often progresses gradually, and most people have many years of productive living after a diagnosis. Complications of Parkinson’s disease are serious; they include difficulties with swallowing, mental health disorders (depression, anxiety), sleep disorders, bladder problems, and constipation.

Prevention:

Because the cause of Parkinson’s is unknown, proven ways to prevent the disease also remain a mystery. Some research has shown that regular aerobic exercise might reduce the risk of Parkinson’s disease. Some other research has shown that people who consume caffeine — which is found in coffee, tea and cola — get Parkinson’s disease less often than those who don’t drink it.

Epidemiology:

Parkinson’s disease affects all ethnic groups worldwide. However, a slightly higher incidence has been reported in the Western hemisphere compared to the Eastern hemisphere. The disease is more common in older individuals, with a median age of onset around 60 years. Men are 1.5 times more likely to have Parkinson’s disease than women.

Parkinson’s disease connection to Small Fiber Neuropathy (SFN)

Association:

Parkinson’s disease (PD) and Small Fiber Neuropathy (SFN) are both neurological disorders, and research has suggested a connection between the two.

  • Neurodegeneration: Parkinson’s disease is a neurodegenerative disorder that primarily affects the dopaminergic neurons in the substantia nigra, a part of the brain. SFN, on the other hand, affects the small myelinated A-delta fibers and the unmyelinated C fibers. The commonality in both conditions is the degeneration of neurons, suggesting a possible link.

  • Autonomic Dysfunction: Parkinson’s disease often involves autonomic dysfunction, which can affect the peripheral nervous system. This could potentially lead to SFN. Autonomic symptoms in PD, such as orthostatic hypotension, constipation, and urinary symptoms, have been associated with SFN.

  • Alpha-synuclein Accumulation: Accumulation of alpha-synuclein, a protein, is a hallmark of Parkinson’s disease. Studies have found that alpha-synuclein can also be present in skin nerve fibers of PD patients, suggesting a possible connection to SFN.

Research Updates:

Recent studies continue to explore the connection between Parkinson’s disease and SFN.

  • A 2020 study published in the Journal of Parkinson’s Disease found that SFN can be an early sign of PD, even before motor symptoms appear. This suggests that SFN could potentially be used as a biomarker for early PD diagnosis.

  • Another 2020 study published in the European Journal of Neurology found that PD patients with SFN had a higher frequency of autonomic symptoms, further supporting the link between autonomic dysfunction in PD and SFN.

  • A 2021 study in the Journal of Neurology found that the presence of SFN in PD patients was associated with more severe autonomic symptoms and a higher risk of falls. This suggests that SFN could be a contributing factor to some of the non-motor symptoms seen in PD.

Symptoms of Parkinson’s disease

List of Symptoms:

Parkinson’s disease is a neurodegenerative disorder that primarily affects dopamine-producing neurons in the brain. It is not directly associated with Small Fiber Neuropathy (SFN), but both conditions can coexist in a patient. Here are the common symptoms of Parkinson’s disease:

  • Tremors: Shaking usually begins in a limb, often your hand or fingers. You may notice a back-and-forth rubbing of your thumb and forefinger, known as a pill-rolling tremor. One characteristic sign is a tremor of your hand when it is relaxed (resting tremor).
  • Slowed movement (bradykinesia): Over time, Parkinson’s disease may reduce your ability to move and slow your movement, making simple tasks difficult and time-consuming. Your steps may become shorter when you walk, or you may find it difficult to get out of a chair. Also, you may drag your feet as you try to walk, making it difficult to move.
  • Rigid muscles: Muscle stiffness may occur in any part of your body. The stiff muscles can limit your range of motion and cause you pain.
  • Impaired posture and balance: Your posture may become stooped, or you may have balance problems as a result of Parkinson’s disease.
  • Loss of automatic movements: In Parkinson’s disease, you may have a decreased ability to perform unconscious movements, including blinking, smiling, or swinging your arms when you walk.
  • Speech changes: You may speak softly, quickly, slur or hesitate before talking. Your speech may be more of a monotone rather than with the usual inflections.
  • Writing changes: It may become hard to write, and your writing may appear small.

Severity:

The severity of Parkinson’s disease symptoms can vary widely among individuals. The disease is often categorized into five stages:

  • Stage 1: Mild symptoms that generally do not interfere with daily activities. Tremor and other movement symptoms occur on one side of the body only. Changes in posture, walking, and facial expressions occur.
  • Stage 2: Symptoms worsen with tremor, rigidity, and other movement symptoms affecting both sides of the body. Walking problems and poor posture may be apparent. The person is still able to live alone, but daily tasks are more difficult and lengthy.
  • Stage 3: Considered mid-stage, loss of balance and slowness of movements are hallmarks. Falls are common. The person is still fully independent, but symptoms significantly impair activities such as dressing and eating.
  • Stage 4: Symptoms are severe and limiting. It’s possible to stand without assistance, but movement may require a walker. The person needs help with activities of daily living and is unable to live alone.
  • Stage 5: This is the most advanced and debilitating stage. The person may not be able to stand or walk, may require a wheelchair, and may be bedridden. Around-the-clock nursing care is required for all activities. The person may experience hallucinations and delusions.

Onset:

Symptoms of Parkinson’s disease usually begin gradually and get worse over time. As the disease progresses, people may have difficulty walking and talking. Symptoms often begin on one side of your body and usually remain worse on that side, even after symptoms begin to affect both sides.

Early symptoms are subtle and occur gradually. They may be mild and go unnoticed. Symptoms often begin on one side of your body and usually remain worse on that side, even after symptoms begin to affect both sides.

In the later stages of the disease, some people develop problems with memory and mental clarity. Alzheimer’s drugs appear to alleviate some of these symptoms to a minor degree.## Diagnosis of Parkinson’s disease

Diagnosis of Parkinson’s disease

Methods:

Parkinson’s disease is primarily diagnosed based on clinical symptoms and physical examination. There are no specific tests for Parkinson’s disease, but certain procedures and tests may be used to rule out other conditions and support the diagnosis. These include:

  • Medical history: The physician will review the patient’s medical history, including onset and progression of symptoms, family history of Parkinson’s disease, and exposure to medications or toxins.

  • Neurological examination: The physician will evaluate the patient’s motor skills, balance, coordination, and other aspects of neurological function.

  • Response to Parkinson’s medication: If the diagnosis is uncertain, the physician may prescribe a Parkinson’s medication (typically levodopa). A significant improvement in symptoms after starting the medication can support the diagnosis of Parkinson’s disease.

  • Imaging tests: While not typically used to diagnose Parkinson’s disease, brain scans such as MRI, CT, or PET may be used to rule out other conditions. A specialized type of PET scan called a DaTscan can show the dopamine system in the brain, which is often abnormal in Parkinson’s disease.

Differential Diagnosis:

Several other conditions can have similar symptoms to Parkinson’s disease and may be mistaken for it, especially in the context of small fiber neuropathy (SFN). These include:

  • Multiple system atrophy (MSA): This is a rare neurological disorder that impairs the body’s involuntary functions (blood pressure, heart rate, bladder function, etc.). It can cause parkinsonism, or Parkinson’s-like symptoms.

  • Progressive supranuclear palsy (PSP): This is a rare brain disorder that causes problems with balance, movement, vision, speech, and swallowing. It can also cause Parkinson’s-like symptoms.

  • Lewy body dementia (LBD): This is a type of progressive dementia that leads to a decline in thinking, reasoning, and independent function. Its most common symptoms mimic those of Parkinson’s disease.

  • Normal pressure hydrocephalus (NPH): This condition, which is caused by an accumulation of cerebrospinal fluid in the brain’s cavities, can cause problems with walking, bladder control, and thinking - symptoms that can be mistaken for Parkinson’s disease.

Limitations:

There are several challenges and limitations in diagnosing Parkinson’s disease:

  • Lack of definitive tests: There are no specific tests that can definitively diagnose Parkinson’s disease. The diagnosis is primarily based on clinical symptoms and response to medication, which can be subjective.

  • Overlap with other conditions: Many other conditions can cause similar symptoms to Parkinson’s disease, making it difficult to distinguish between them. This is especially true in the early stages of the disease.

  • Variability of symptoms: The symptoms of Parkinson’s disease can vary greatly from person to person, and not everyone will have all of the typical symptoms. This can make the diagnosis more challenging.

  • Response to medication: Not everyone with Parkinson’s disease responds to levodopa, the most common medication used to treat the disease. This can make it difficult to confirm the diagnosis based on response to medication.## Treatments for Parkinson’s disease

Treatments for Parkinson’s disease

Options:

  • Medications: The most common treatment for Parkinson’s disease is medication. Levodopa, a drug that the brain converts into dopamine, is often prescribed. Other medications include dopamine agonists (which mimic dopamine in the brain), MAO-B inhibitors (which help prevent the breakdown of brain dopamine), and others that help control the non-motor symptoms of Parkinson’s disease.

  • Deep Brain Stimulation (DBS): DBS is a surgical procedure used to treat Parkinson’s disease symptoms. It involves implanting a device that sends electrical signals to brain areas responsible for body movement.

  • Physical Therapy: Physical therapy can help manage problems with balance and flexibility in Parkinson’s disease patients. It can also help improve strength and reduce the risk of falls.

  • Occupational Therapy: This therapy can help patients with Parkinson’s disease maintain their independence by helping them with daily activities such as eating, dressing, and writing.

  • Speech-Language Therapy: Parkinson’s disease can cause problems with speech and swallowing. Speech-language therapy can help manage these issues.

When Parkinson’s disease is linked to Small Fiber Neuropathy (SFN), the treatment approach might also involve managing the symptoms of SFN, such as pain and numbness. This can include pain relievers, anti-seizure medications, and antidepressants.

Effectiveness:

  • Medications: Levodopa is often very effective at reducing the motor symptoms of Parkinson’s disease, especially in the early stages. However, its effectiveness can decrease over time, and it can cause side effects such as involuntary movements.

  • Deep Brain Stimulation (DBS): DBS can be very effective for some people with Parkinson’s disease. It can significantly improve quality of life and reduce the need for medication. However, it doesn’t work for everyone and it can have serious side effects.

  • Physical, Occupational, and Speech-Language Therapy: These therapies can help manage the symptoms of Parkinson’s disease and improve quality of life. However, they don’t slow down the progression of the disease.

Side Effects:

  • Medications: Side effects of Parkinson’s disease medications can include nausea, low blood pressure, and hallucinations. Levodopa can also cause involuntary movements.

  • Deep Brain Stimulation (DBS): Risks associated with DBS include infection, stroke, and problems with speech or balance.

  • Physical, Occupational, and Speech-Language Therapy: These therapies are generally safe, but they can be tiring and require a significant time commitment.

Recent Advancements:

Recent advancements in the treatment of Parkinson’s disease include:

  • Neuromodulation: This is a new technique that uses magnetic or electrical stimulation to regulate nerve activity. It’s still in the experimental stages for Parkinson’s disease.

  • Gene Therapy: Researchers are exploring the use of gene therapy to change the activity of certain cells in the brain. This could potentially slow down the progression of Parkinson’s disease.

  • Stem Cell Therapy: This involves using stem cells to replace damaged or lost neurons in the brain. It’s still in the early stages of research.

  • New Medications: There are several new medications in development for Parkinson’s disease, including drugs that could potentially slow down or stop the progression of the disease.